Skip to main content
Clinical Trials/NCT05654363
NCT05654363
Completed
Not Applicable

The Role of Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy: an Observational Retrospective Study (the SPIN_GYN Study)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 site in 1 country670 target enrollmentMarch 13, 2023

Overview

Phase
Not Applicable
Intervention
Administration of morphine by intrathecal route
Conditions
Pain, Postoperative
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
670
Locations
1
Primary Endpoint
Numeric pain rating scale (NPRS)
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

Perioperative multimodal analgesia, defined by the use of various analgesic medications targeting different drug receptors, provides adequate pain relief with minimal or no opiate consumption. Therefore, it represents one of the cornerstone of Enhanced Recovery After Surgery (ERAS) protocols, as the reduction in opioid use and the associated side effects may eventually reduce length of hospital stay, increase patient satisfaction and minimise the risk of long-term opioid use.

Regional and neuraxial anesthesia techniques are key interventions to provide successful analgesia in the context of a multimodal strategy. Intrathecal morphine, for its effectiveness and potential of reducing the need of intravenous postoperative opioids, seems an attractive option in the case of hysterectomy, one of the most common major surgical procedures performed in women, associated with severe postoperative pain even when performed laparoscopically.

The aim of our observational retrospective study is therefore to compare the analgesic efficacy and the safety of morphine administered by intrathecal route versus intravenous route during the first 48 hours after performance of laparoscopic/laparotomic hysterectomy.

Registry
clinicaltrials.gov
Start Date
March 13, 2023
End Date
June 1, 2023
Last Updated
2 months ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult women American Society of Anaesthesiologists (ASA) physical status \<= 3, scheduled for elective hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021.

Exclusion Criteria

  • patients with American Society of Anaesthesiologists (ASA) status \> 3,
  • opioid use or history of opioid dependence,
  • chronic use of analgesic medications,
  • psychiatric disorders.

Arms & Interventions

Intrathecal morphine

Adult women American Society of Anaesthesiologists (ASA) physical status \<= 3, scheduled for elective laparoscopic/laparotomic hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021, who consented to the execution of a preoperative spinal analgesia with intrathecal morphine (as part of our standard practice) and who did not present any contraindications to lumbar puncture.

Intervention: Administration of morphine by intrathecal route

Intravenous morphine

Adult women American Society of Anaesthesiologists (ASA) physical status \<= 3, scheduled for elective laparoscopic/laparotomic hysterectomy under general anesthesia between January 1st 2019 and December 31st 2021, who did not consent to the execution of a preoperative spinal analgesia or presented contraindications to lumbar puncture (coagulopathy or incorrect discontinuation of anticoagulant drugs, increased intracranial pressure, infection at the site of injection, major spinal deformities).

Intervention: Administration of morphine by intravenous route

Outcomes

Primary Outcomes

Numeric pain rating scale (NPRS)

Time Frame: 48 hours from baseline

Numeric pain rating scale (NPRS) (ranging from 0, "no pain" and 10, "the worst pain imaginable") at rest

Numeric pain rating scale (NPRS)

Time Frame: Time 0 (= baseline, i.e. at the time of Postoperative Anesthesia Care Unit arrival)

Numeric pain rating scale (NPRS) (ranging from 0, "no pain" and 10, "the worst pain imaginable") at rest

Numeric pain rating scale (NPRS)

Time Frame: 6 hours from baseline

Numeric pain rating scale (NPRS) (ranging from 0, "no pain" and 10, "the worst pain imaginable") at rest

Numeric pain rating scale (NPRS)

Time Frame: 12 hours from baseline

Numeric pain rating scale (NPRS) (ranging from 0, "no pain" and 10, "the worst pain imaginable") at rest

Numeric pain rating scale (NPRS)

Time Frame: 24 hours from baseline

Numeric pain rating scale (NPRS) (ranging from 0, "no pain" and 10, "the worst pain imaginable") at rest

Secondary Outcomes

  • Length of hospital stay(Time from dismissal from PACU to dismissal from hospital, an average of 72 hours)
  • Intraoperative opioid consumption(During the surgery)
  • Mobilization(After the end of surgery, in the first 48 postoperative hours)
  • Postoperative opioid consumption(After the end of surgery, in the first 48 postoperative hours)
  • Adverse events(After the end of surgery, in the first 48 postoperative hours)
  • Constipation(After the end of surgery, in the first 48 postoperative hours)
  • Rescue analgesia(After the end of surgery, in the first 48 postoperative hours)
  • Length of PACU stay(Time from admission to dismissal from PACU, an average of 1 hour)

Study Sites (1)

Loading locations...

Similar Trials